The best online GLP-1 program clearly identifies the medication and pharmacy, uses a licensed clinician to decide whether treatment is appropriate, explains the full cost before enrollment, and provides follow-up support. Compare FDA-approved and compounded options carefully, because medication form, evidence, availability, and pricing can differ.
Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →How did we evaluate online GLP-1 programs?
We evaluated program types by five practical factors: prescriber review, medication clarity, pharmacy disclosure, follow-up access, and total cost transparency. These factors matter because GLP-1 and GIP/GLP-1 medicines can cause gastrointestinal adverse effects and have important warnings that need individual clinical review. 1 2
- A licensed US clinician reviews your health history before prescribing, rather than offering medication without an evaluation.
- The program names the exact medication, form, and dispensing pharmacy or clearly explains how those details are provided.
- The price makes clear whether it includes medication, clinical visits, shipping, refill support, and required follow-ups.
- You can contact the care team about adverse effects, treatment changes, or questions between visits.
- The program does not promise a prescription, guaranteed results, or medication without a valid prescription.
What are the best online GLP-1 program options for different needs?
There is no single best choice for everyone. The best fit depends on your medication path and budget, including whether you are using insurance, paying cash for an FDA-approved product, or discussing a compounded option with a clinician.
1. Insurance-focused programs: best for help navigating FDA-approved options
Programs built around insurance navigation may be useful when you want help pursuing an FDA-approved product such as Wegovy (semaglutide, a GLP-1 receptor agonist) or Zepbound (tirzepatide, a dual GIP and GLP-1 receptor agonist). Wegovy and Zepbound have weight-management indications for certain adults, while Ozempic and Mounjaro are labeled for type 2 diabetes. 1 2 3 4
- Best for: people whose insurance may cover a labeled medication.
- What to verify: prior-authorization support, visit fees, pharmacy network rules, and the cost if coverage is denied.
- Limitations: insurance approval is not guaranteed, and out-of-pocket costs can still be substantial.
2. Cash-pay programs with FDA-approved medication: best for clear brand-product access
Some telehealth programs prescribe FDA-approved products through standard pharmacy channels for self-pay patients. FDA-approved products have product-specific labeling, including indications, contraindications, warnings, and dose-escalation instructions for clinicians and patients. 1 2
- Best for: people who want a labeled product and can confirm the all-in cash price.
- What to verify: whether the advertised price includes the medication itself or only the membership and prescribing visit.
- Limitations: published prices can change, and medication availability varies by pharmacy and location.
3. Chia: best for clinician-reviewed compounded GLP-1 options with transparent starting prices
At Chia, we offer an online path for patients considering compounded semaglutide or compounded tirzepatide. Our plans currently start at $249 per month for semaglutide injection, $249 per month for tirzepatide tablets, and $299 per month for tirzepatide injection; visit the product pages for current details.
- Best for: self-pay patients seeking an online clinician evaluation for a compounded GLP-1 option.
- What Chia offers: compounded semaglutide injection, plus compounded tirzepatide tablets or injections; microdosing plans may be available when clinically appropriate.
- Care model: a licensed US provider reviews your questionnaire, provides a prescription only when clinically appropriate, and can guide adjustments over time.
- Pharmacy model: medications are compounded in the US by state-licensed 503A pharmacies and shipped to your door.
- Limitation: compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality in the same way as FDA-approved products. 5
4. Coaching-heavy programs: best when structured behavior support is your priority
Some programs combine medical visits with frequent nutrition, activity, or behavioral coaching. Medication is only one part of weight management, and the appropriate program should account for medical history, other medicines, food access, sleep, and realistic follow-up needs. 6
- Best for: people who want regular coaching alongside medical care.
- What to verify: whether coaching is optional, whether it is included in the listed price, and how often you can reach a prescriber.
- Limitations: more coaching can raise the monthly cost without changing medication access.
| Program type | Prescriber evaluation | Medication model | What to compare | Common trade-off |
|---|---|---|---|---|
| Insurance-focused telehealth | Usually required before prescribing | Often FDA-approved products through retail pharmacies | Coverage support, visit costs, prior authorization | Coverage may be denied or delayed |
| Cash-pay brand-medication telehealth | Usually required before prescribing | FDA-approved product paid out of pocket | Medication price versus membership fee | Higher self-pay cost |
| Chia | Licensed-provider review required | Compounded semaglutide injection; compounded tirzepatide tablets or injections | Starting price, form, portal support, 503A pharmacy disclosure | Compounded medications are not FDA-approved |
| Coaching-heavy program | Varies by program | May coordinate medication plus coaching | Frequency of coaching and total monthly fee | More services may mean higher cost |
What makes an online GLP-1 program a good fit?
A good program is transparent before you enroll. A real clinical evaluation comes before a prescription decision, because GLP-1 medicines are not appropriate for every person and may interact with a person’s medical history or treatment plan. 1 2
A licensed clinician evaluates eligibility before prescribing
Look for a program that collects a health history and has a licensed US clinician review it. FDA labeling for semaglutide and tirzepatide includes contraindications and warnings that require individualized assessment, including a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. 1 2
The program clearly states what medication and form may be prescribed
Semaglutide may refer to Wegovy or Ozempic, but these branded products have different labeled uses. Tirzepatide may refer to Zepbound or Mounjaro, which also have different labeled uses. A program should also plainly state when it is discussing compounded semaglutide or compounded tirzepatide rather than an FDA-approved branded product. 1 2 3 4 5
The total monthly cost is understandable before enrollment
Ask for the full monthly cost, not just an introductory offer. The useful number includes medication, membership, prescribing visits, shipping, follow-up appointments, and any separate charges that apply when treatment changes.
Follow-up care and side-effect support are available
Nausea, vomiting, diarrhea, constipation, and abdominal pain are among the common adverse reactions listed for semaglutide and tirzepatide products. Follow-up matters because a clinician may need to assess symptoms, hydration concerns, other medications, or whether treatment remains appropriate. 1 2
3-min quiz
Compare your GLP-1 options with a clinician
Chia’s online questionnaire starts a licensed-provider evaluation for compounded semaglutide or compounded tirzepatide when clinically appropriate. A prescription requires a medical evaluation and is not guaranteed. Compounded medications are prepared by state-licensed 503A pharmacies and are not FDA-approved.
Which GLP-1 medications might an online program discuss?
Online programs may discuss two common active ingredients: semaglutide and tirzepatide. They are related but not identical medicines, and branded products have different FDA-approved indications depending on the product. 1 2 3 4
Semaglutide: Wegovy and Ozempic
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. Wegovy is labeled for chronic weight management in certain patients, while Ozempic is labeled to improve blood sugar control in adults with type 2 diabetes and for certain cardiovascular and kidney-risk indications in that population. 1 3
In STEP 10, a randomized trial in adults with obesity and prediabetes, investigators compared once-weekly 2.4 mg semaglutide with placebo. The trial reported weight and glycemic outcomes for the studied FDA-approved semaglutide regimen; individual results vary. Gastrointestinal effects and labeled contraindications remained important safety considerations. 6 1
Tirzepatide: Zepbound and Mounjaro
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. Zepbound is labeled for chronic weight management in certain patients, while Mounjaro is labeled to improve blood sugar control in adults with type 2 diabetes. 2 4
Tirzepatide and semaglutide have been compared in research, but comparison methods and participant groups matter. A 2025 indirect comparison in people with type 2 diabetes and overweight or obesity evaluated tirzepatide 10 mg and 15 mg against semaglutide 2.4 mg; an indirect comparison does not replace a direct head-to-head randomized trial. Digestive adverse effects and individual contraindications still need clinician review. 7 1 2
FDA-approved medicines versus compounded semaglutide and compounded tirzepatide
FDA-approved medicines undergo FDA review for safety, effectiveness, and manufacturing quality for their labeled uses. Compounded drugs are not FDA-approved, and FDA does not review compounded products before marketing in the same way it reviews approved drugs. That means trial findings for an FDA-approved branded product should not be presented as established outcome data for a compounded formulation. 5
Are online GLP-1 providers legitimate and safe?
Online care can be legitimate when it follows the same basic safeguards as other prescription care. The key safety check is licensed clinical and pharmacy oversight, not whether the visit happens by video, messaging, or another telehealth format.
- Verify that a licensed clinician reviews your health history and makes the prescribing decision.
- Ask which pharmacy will dispense the medication. For compounded medication, ask whether it is a state-licensed 503A compounding pharmacy.
- Avoid sellers that offer prescription medication without a prescription, do not identify ingredients, or make guaranteed-weight-loss claims.
- Be cautious with unlicensed “research chemical” sellers. Their products are not a substitute for medication supplied through a licensed clinician and pharmacy.
- Review the program’s cancellation terms, refill process, and route for reporting side effects before enrolling.
What should you know about effectiveness and side effects before choosing a program?
GLP-1 medicines can affect appetite, blood sugar signaling, and stomach emptying. Clinical-trial results describe groups, not guarantees for an individual, and the right medication choice depends on your health history, goals, tolerance, and other medicines. 1 2 6
Semaglutide has been studied in randomized trials of people with obesity and prediabetes, as well as in people with obesity-related heart failure with preserved ejection fraction. These studies provide human evidence for the active ingredient in the studied product and population, but they do not establish the same outcomes for compounded formulations. 6 8
Common gastrointestinal adverse effects listed in semaglutide and tirzepatide labeling include nausea, diarrhea, vomiting, constipation, abdominal pain, and indigestion. Both labels also include important warnings, including risks related to pancreatitis, gallbladder disease, and dehydration-related kidney problems; a clinician can help assess what these warnings mean in your situation. 1 2
What is the cheapest way to get a GLP-1 without insurance?
The cheapest option is not always the lowest advertised starting number. Compare at least three months of all-in cost because introductory rates, membership fees, medication charges, and follow-up requirements may differ.
- 1Ask whether the stated price includes medication, clinician visits, shipping, supplies, and refills.
- 2Ask whether the price changes when a clinician adjusts treatment or recommends a different medication form.
- 3Separate FDA-approved product prices from compounded-medication prices; they are different medication pathways with different regulatory status.
- 4Confirm whether the program bills monthly, requires a multi-month commitment, or charges a cancellation fee.
- 5Use a written cost comparison. Our guide to weight-loss drug costs can help you compare medication, care, and insurance questions.
If you are comparing compounded medication, price should not be your only filter. Confirm the clinician relationship, the pharmacy’s state licensure, the exact formulation, and how the program handles follow-up. FDA advises patients to understand that compounded drugs are not FDA-approved. 5
How do online GLP-1 programs work at Chia?
At Chia, care begins with a 100% online health questionnaire and a licensed US provider’s review. If treatment is clinically appropriate, the provider may prescribe compounded semaglutide or compounded tirzepatide and guide adjustments over time; eligibility and prescriptions are never guaranteed.
We offer compounded semaglutide as an injection. We offer compounded tirzepatide as tablets or injections, and microdosing plans are available for semaglutide and tirzepatide when clinically appropriate. Medications are compounded in the United States by state-licensed 503A pharmacies, shipped to the patient’s door, and supported through patient-portal messaging between visits.
| Chia treatment | Available form | Current starting price | Care details |
|---|---|---|---|
| Compounded semaglutide | Injection | From $249/mo | Provider-guided care; microdosing plans may be available when clinically appropriate |
| Compounded tirzepatide | Tablets | From $249/mo | Provider-guided care; microdosing plans may be available when clinically appropriate |
| Compounded tirzepatide | Injection | From $299/mo | Provider-guided care; microdosing plans may be available when clinically appropriate |
Our online model may be useful if you want a clinician-reviewed compounded option and clear form choices. You can also review our guides to online semaglutide providers and the best way to get tirzepatide online before deciding what questions to ask.
What should you ask before enrolling in an online GLP-1 program?
Ask direct questions before entering payment information. Five minutes of clear questions can prevent months of confusion about cost, pharmacy sourcing, and follow-up.
- Who reviews my medical history, and what type of licensed clinician may prescribe?
- What exact medication and form might be prescribed, and what is its FDA approval status?
- Which pharmacy dispenses the medication, and is it state licensed?
- What is my expected all-in monthly cost, including medication, visits, shipping, and refills?
- How do I contact the care team about side effects or questions?
- What happens if the clinician determines this treatment is not appropriate?
- How are follow-ups, treatment changes, and cancellations handled?
A quality program should answer these questions plainly. For a broader comparison of medication paths, see our guide to the best GLP-1 medications for weight loss.
3-min quiz
Start with an online clinical evaluation
If you are considering a compounded GLP-1 path, Chia can connect you with a licensed US provider for an online review. We offer compounded semaglutide injection and compounded tirzepatide tablets or injections when clinically appropriate. A prescription is not guaranteed, and compounded medications are not FDA-approved.
What are common questions about online GLP-1 programs?
The best program is the one that fits your medication path, budget, and support needs. Look for licensed clinician review, clear pharmacy information, transparent all-in pricing, and a reliable way to get follow-up help.
A licensed clinician may prescribe medication through telehealth when it is clinically appropriate and permitted under applicable rules. A program should require a real medical evaluation and should not guarantee a prescription.
No. Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality in the same way as FDA-approved products. A clinician can explain the medication pathway being considered and its limits.
It can be, but not always. Compare the full monthly cost of medication, visits, shipping, memberships, required follow-ups, and any charges that may change over time.
No legitimate program should provide prescription GLP-1 medication without a prescription decision from a licensed clinician. Avoid sellers that skip medical review or do not identify their pharmacy.
Ask what medication and form may be prescribed, which state-licensed pharmacy prepares it, what the full price includes, how follow-up works, and how the care team handles questions or adverse effects.
Chia offers online licensed-provider evaluations for compounded semaglutide injection and compounded tirzepatide tablets or injections when clinically appropriate. Chia also offers microdosing plans for these treatments when clinically appropriate, but prescriptions are not guaranteed.
References
- 1.U.S. Food and Drug Administration. Wegovy (semaglutide) prescribing information. 2025.
- 2.U.S. Food and Drug Administration. Zepbound (tirzepatide) prescribing information. 2025.
- 3.U.S. Food and Drug Administration. Ozempic (semaglutide) prescribing information. 2025.
- 4.U.S. Food and Drug Administration. Mounjaro (tirzepatide) prescribing information. 2025.
- 5.U.S. Food and Drug Administration. Understanding the risks of compounded drugs. 2024.
- 6.McGowan BM, Bruun JM, Capehorn M, et al. Efficacy and safety of once-weekly semaglutide 2.4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial. The Lancet Diabetes & Endocrinology. 2024.
- 7.Ciudin A, Johansson E, Zimner-Rapuch S, et al. Indirect comparative efficacy and safety of tirzepatide 10 and 15 mg versus semaglutide 2.4 mg for the management of obesity and overweight in patients with type 2 diabetes. Diabetes, Obesity and Metabolism. 2025.
- 8.Butler J, Shah SJ, Petrie MC, et al. Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials. Lancet. 2024.
- 9.U.S. Food and Drug Administration. Compounding and the FDA: questions and answers. 2024.
- 10.National Institute of Diabetes and Digestive and Kidney Diseases. Prescription medications to treat overweight and obesity. 2024.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
